Evaluation of Feasibility and Image Quality of 68Ga-DOTATOC Positron Emission Tomography/Magnetic Resonance in Comparison With Positron Emission Tomography/Computed Tomography in Patients With Neuroendocrine Tumors-Reference-Cited by-同舟云学术

Evaluation of Feasibility and Image Quality of 68Ga-DOTATOC Positron Emission Tomography/Magnetic Resonance in Comparison With Positron Emission Tomography/Computed Tomography in Patients With Neuroendocrine Tumors

Published:2013-05 Issue:5 Volume:48 Page:263-272
ISSN:0020-9996
Container-title:Investigative Radiology
language:en
Short-container-title:Investigative Radiology

Author:

Gaertner Florian C.,Beer Ambros J.,Souvatzoglou Michael,Eiber Matthias,Fürst Sebastian,Ziegler Sybille I.,Brohl Florian,Schwaiger Markus,Scheidhauer Klemens

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference25 articles.

1. Current Status of Gastrointestinal Carcinoids

2. Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data

3. 68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

4. Bone Metastases in Patients with Neuroendocrine Tumor: 68Ga-DOTA-Tyr3-Octreotide PET in Comparison to CT and Bone Scintigraphy

5. The Role of 68Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on 111In-DTPA-Octreotide Scintigraphy

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms;World Journal of Gastrointestinal Endoscopy;2022-05-16

2. A novel read methodology to evaluate the optimal dose of 68Ga-satoreotide trizoxetan as a PET imaging agent in patients with gastroenteropancreatic neuroendocrine tumours: a phase II clinical trial;EJNMMI Research;2021-09-06

3. Neuroendocrine Tumors;PET Clinics;2021-07

4. Imaging and its Impact on Defining the Oligometastatic State;Seminars in Radiation Oncology;2021-07

5. Imaging of neuroendocrine tumors: A pictorial review of the clinical value of different imaging modalities;Reviews in Endocrine and Metabolic Disorders;2021-03-30